Aisling Capital’s Dennis Purcell believes a change in the dynamics of the pharmaceutical industry spells good fortune for life sciences investors. By Ken MacFadyen.
2 min read · 30 December 2012
Crestview Partners, the new firm launched by Goldman Sachs veterans Barry Volpert and Thomas Murphy, has yet to formally announce a final close for its debut fund, but in statement announcing its first deal, the firm said it had amassed $1.4bn in commitments.
2 min read · 30 December 2012
Investcorp wrapped up the fundraising for its second ‘venture-buyout’ fund, closing on $300m for its Investcorp Technology Ventures II. The fund, which was oversubscribed, exceeded its target by $50m.
2 min read · 30 December 2012
Boston-based JW Childs lost a key ruling in an indemnification suit the firm levied against the former owners of Hartz Mountain, a pet supplies company the firm had owned between 2000 and 2004.
3 min read · 30 December 2012
Los Angeles-based Hancock Park is seeking $250m for its third fund, more than doubling its take for the 2003-vintage Hancock Park Capital II.
2 min read · 30 December 2012
The Blackstone Group has finalised its purchase of Dallas-based La Quinta Corp., paying $3.4bn for the hotel operator.
1 min read · 30 December 2012
Silver Lake Partners agreed to take Serena Software private for roughly $1.2 billion, in what has been a busy week for public-to-private transactions.
2 min read · 30 December 2012
Draper Fisher Jurvetson’s clean-energy affiliate fund, DFJ Element, has held an interim close, with backing coming from CalPERS and Swiss Re, among others.
2 min read · 30 December 2012
The WL Ross & Co. joint venture with Lear Corp. and Franklin Mutual Advisors has agreed to acquire a significant chunk of Collins & Aikman’s European operations.
2 min read · 30 December 2012
Sentinel Capital Partners has scored a roughly 4x return through the sale of Alemite, a Fort Mill, South Carolina-based industrial lubrication company.
2 min read · 30 December 2012
